Lifeline Drugs & Pharma (Delisted) share price history
BSE: 506113Retailing
Last traded ₹134.40 on 27 Aug 2015
Delisted on 23 Nov 2023.
Last announcements
The company's own last announcements before its shares stopped trading, routine notices left out.Share news and announcements
Jan 2020
Apr 2019
29 Apr · Reg. 34 (1) Annual Report
Nov 2018
Results
Standalone; ₹ crore, the charts by years to March, the table by quarter. No standalone results on record for the years to Mar 2011 and Mar 2016.Quarterly results
Quarter to Mar 2018, against the quarter beforeFiled 30 Nov
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹3.40 Crup 1,628.25%
- Net profit
- −₹0.50 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- −14.6%
Revenue by year
Peak revenue ₹62 Cr, year to Mar 2010
Net profit by year, a loss in red
| ₹ crore | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017Filed 27 Nov | Sep 2017Filed 30 Nov | Dec 2017Filed 30 Nov | Mar 2018Filed 30 Nov |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.50 | – | – | 2.98 | 0.36 | 0.19 | 0.20 | 3.40 |
| Net profit | 0.22 | 0.28 | 0.28 | −0.76 | 0.22 | 0.12 | 0.15 | −0.50 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 44.0% | – | – | −25.6% | 61.7% | 64.2% | 77.9% | −14.6% |
Standalone. The last eight quarters. The latest is shaded.
Business segments
Share of revenue, year to Mar 2018, standalone.Segment revenue and profit
- Finance and Investment activitiesFinance and Investment activities, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹4.86 Cr94.5%
- Textile ActivitiesTextile Activities, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹0.26 Cr5.0%
- Steel ActivitiesSteel Activities, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹0.02 Cr0.5%
Lifeline Drugs & Pharma share price by year
Each calendar year to 2015.
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2015 | 134.40 | −46.7% | 264.90 | 134.40 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The 2015 close is its last trade, on 27 Aug 2015.
Recent sessions
The last 10 trading days to 27 Aug 2015, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 27 Aug 2015 | 134.40 | 134.40 | 134.40 | 134.40 | 134.40 | 1,774 |
| 26 Aug 2015 | 168.00 | 247.90 | 167.90 | 167.90 | 168.05 | 7,691 |
| 25 Aug 2015 | 167.30 | 230.00 | 167.30 | 209.80 | 209.89 | 17,628 |
| 24 Aug 2015 | 213.00 | 229.80 | 206.00 | 206.00 | 210.11 | 9,057 |
| 21 Aug 2015 | 225.10 | 240.00 | 222.90 | 231.00 | 231.49 | 16,449 |
| 20 Aug 2015 | 227.00 | 230.00 | 227.00 | 230.00 | 227.00 | 4,201 |
| 19 Aug 2015 | 231.00 | 231.00 | 230.00 | 230.00 | 230.00 | 200 |
| 18 Aug 2015 | 216.00 | 233.00 | 216.00 | 229.50 | 225.71 | 27,591 |
| 17 Aug 2015 | 212.10 | 219.90 | 212.00 | 216.80 | 215.59 | 5,714 |
| 14 Aug 2015 | 201.00 | 220.00 | 201.00 | 216.00 | 213.48 | 39,126 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 14 Nov 2013 | Price move | – | Between two trading sessions the price fell 47% or more, or rose 90% or more. The company made an announcement in time for trading that day or the trading day before. Earlier prices are not shown. |
| 10 Jan 2013 | Price move | – | Between two trading sessions the price fell 47% or more, or rose 90% or more. No corporate action is on record. Earlier prices are not shown. |
Where an event has no factor that can be worked out, the chart leaves out the closes before it.
Company details
- Legal name
- Lifeline Drugs & Pharma Ltd
- BSE code
- 506113
- ISIN
- INE776N01028
- Industry
- Retailing
- Listed
- Jun 1983
- Face value
- ₹1
- CIN
- L51909MH1982PLC028972
- Corporate identity number, the registrar of companies' code for it